The following organizations are among the non-profit foundations that fund research grants in fields related to the mission of the Scripps Translational Science Institute. Investigators interested in submitting a grant proposal to these or other foundations first should contact the grants officers of their institutions.
The Damon Runyon-Rachleff Innovation Award funds cancer research by exceptionally creative thinkers with “high-risk/high- reward” ideas that have potential to significantly impact cancer, but lack sufficient preliminary data to obtain traditional funding.
SBK funds research to speed translation of discoveries into reductions in breast cancer mortality and/or incidence within the next decade.
AF’s breast cancer research program awards grants for translational studies.
ACS Research Scholar Grants support investigator-initiated research of scientists in first six years of an independent career.
AACR funds grants to support studies of independent investigators, young researchers as well as postdoctoral and clinical research fellows.
SU2C grants, administered by AACR, fund novel, high-risk, high reward cancer research proposals have significant potential for translational application, and hold great promise for advancing SU2C’s overarching goal of improving & saving lives of patients.
PCF’s Human Capital Initiative includes Creativity Awards to support studies based on high-risk, high-reward ideas, and Challenge Awards to invest in multi-year projects that have high transformative potential for areas of unmet need in prostate cancer research.
The foundation’s Kimmel Translational Science Award supports physicians engaged in translational science and its Kimmel Scholar Award is designed for researchers (Ph.D. or M.D.) who do not yet have their own R01 funding.
ABTA’s Translational Grants support scientists in the early years of their career to advance studies on the cusp of moving from the laboratory into patient testing.
The foundation awards grants to select doctors and medical scientists focusing on curing cancers that affect women.
Western States Affiliate Grant-in-Aid Program funds innovative and meritorious research projects of independent investigators.
BF supports research in cardiovascular disease.
The foundation funds two awards programs for research in cardiovascular and neurovascular disease: the Transatlantic Networks of Exellence Program, for large, internationally collaborative research networks, and the Career Development Award, to support for junior and senior investigators to conduct studies internationally within the Leducq networks. Based in France, this foundation was created with the idea that the battle against cardiovascular and neurovascular disease should be waged at the international level.
ADA’s grants include the Clinical/Translational Award to support research directly involving humans re: normal physiology & mechanisms of disease. The Innovation Award is a pilot and feasibility grant to support novel hypotheses that may lack preliminary data, but offer considerable promise for preventing and treating diabetes. Note: DNA samples and extensive phenotypic data are available from the association’s GENNID study (Genetics of Non-Insulin Dependent Diabetes Mellitus).
Foundation’s Innovation in Clinical Research Award is designed to catalyze innovative breakthroughs & cross-disciplinary collaborations in targeted areas of clinical research.
WMK’s Medical Research Program supports high risk/high-impact basic research projects that are distinctive & novel in approach to intractable problems, push the edge of their field, or question prevailing paradigm.
The foundation also has a Science and Engineering Research Program that supports distinctive and novel projects that question the prevailing paradigm or have potential to open new territory in the field.
Coulter Translational Research Awards fund scientists with a primary, secondary or affiliated appointment in established academic Biomedical Engineering Dept., to support biomedical
research that is translational & directed at promising technologies with the goal of progressing toward commercial development and entering clinical practice.
Its Science and Technology Program aims to advance promising research and technological developments that have the potential to expand knowledge, improve health, and protect the environment. Specific areas of interest include: (a) intersection of neuroscience and & human genome; and (b) research that results in breakthroughs in medical research & understanding of biological systems. Since grant applications are by invitation, unsolicited proposals are not accepted. However, if your research proposal is aligned with the foundation’s program areas, contact the foundation.
Foundation’s grants support research that will “speed the application of recent translational advances in gene therapy to clinical trials.”
The foundation’s mission “is to foster collaboration in biomedical research in order to accelerate medical innovation and to facilitate commercialization of innovative medical products for the public good.”
The foundation’s Senior Scholar Awards in Aging support established investigators, “to stimulate new research, which has rigorous scientific foundations, but which may not be currently funded adequately, because of its perceived novelty, its high risk, or because it is from an area where traditional research interests absorb most funding.”
SDF’s Science & Technology program designed to “enhance science and technology in San Diego by funding innovative research, emerging scientists, science education, and access to technology.”
According to the WF website: “Believing that goal oriented science can inspire incredible innovation, the foundation fast-forwards projects with focused objectives, achievable milestones & strong strategic plans. We then bring the best minds & global resources together to resolve differences, achieve critical breakthroughs & accelerate progress. We are especially interested in world-scale science projects that pioneer new technologies and forge new educational advances. “
In Feb. 2011, the National Health Council (NHC) launched this national, online database so that “researchers whose meritorious grant proposals were reviewed but not funded by the NIH….” could “ post their abstracts and contact information” for viewing/review by “non-governmental sources seeking to support medical breakthroughs.”